192 related articles for article (PubMed ID: 24942334)
101. The effects of common genetic variants in oncogenes on ovarian cancer survival.
Quaye L; Gayther SA; Ramus SJ; Di Cioccio RA; McGuire V; Hogdall E; Hogdall C; Blaakr J; Easton DF; Ponder BA; Jacobs I; Kjaer SK; Whittemore AS; Pearce CL; Pharoah PD; Song H
Clin Cancer Res; 2008 Sep; 14(18):5833-9. PubMed ID: 18794094
[TBL] [Abstract][Full Text] [Related]
102. Genetic and phenotypic characteristics of Russian patients with BRAF-mutated colorectal cancer.
Loginova A; Shelygin Y; Shubin V; Achkasov S; Ponomarenko A; Shakhmatov D; Skridlevskiy S; Vaganov Y; Kashnikov V; Tsukanov A
Neoplasma; 2021 Sep; 68(5):1091-1097. PubMed ID: 34196213
[TBL] [Abstract][Full Text] [Related]
103. V-Raf murine sarcoma viral oncogene homolog B1 (BRAF) as a prognostic biomarker of poor outcomes in esophageal cancer patients.
Kuerbanjiang A; Maimaituerxun M; Zhang Y; Li Y; Cui G; Abuduhabaier A; Aierken A; Miranbieke B; Anzaer M; Maimaiti Y
BMC Gastroenterol; 2021 Feb; 21(1):86. PubMed ID: 33622273
[TBL] [Abstract][Full Text] [Related]
104. Association between autophagy and KRAS mutation with clinicopathological variables in colorectal cancer patients.
Awi NJ; Yap HY; Armon S; Low JSH; Peh KB; Peh SC; Lee CS; Teow SY
Malays J Pathol; 2021 Aug; 43(2):269-279. PubMed ID: 34448791
[TBL] [Abstract][Full Text] [Related]
105. Assessing the Therapeutic Impacts of HAMLET and FOLFOX on BRAF-Mutated Colorectal Cancer: A Study of Cancer Cell Survival and Mitochondrial Dynamics In Vitro and Ex Vivo.
Žilinskas J; Stukas D; Jasukaitienė A; Žievytė I; Balion Z; Šapauskienė J; Banienė R; Paužas H; Lizdenis P; Čėsna V; Dambrauskas Ž; Gulbinas A; Tamelis A
Medicina (Kaunas); 2024 Jan; 60(1):. PubMed ID: 38256402
[No Abstract] [Full Text] [Related]
106. α4-α5 Helices on Surface of KRAS Can Accommodate Small Compounds That Increase KRAS Signaling While Inducing CRC Cell Death.
Abuasaker B; Garrido E; Vilaplana M; Gómez-Zepeda JD; Brun S; Garcia-Cajide M; Mauvezin C; Jaumot M; Pujol MD; Rubio-Martínez J; Agell N
Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614192
[TBL] [Abstract][Full Text] [Related]
107. Clinicopathological and molecular characteristics of early-onset vs late-onset colorectal cancer according to tumor location.
Chen Y; Chen Z; Huang J; Hu J; He X; Lan P; He X
Int J Clin Oncol; 2022 Apr; 27(4):749-755. PubMed ID: 35079898
[TBL] [Abstract][Full Text] [Related]
108.
Liu X; Yang G; Huang J; Chai L; Liu X; Dai Q; Yang Z
Biomark Med; 2020 Jan; 14(1):13-22. PubMed ID: 31729889
[No Abstract] [Full Text] [Related]
109. Concurrence of a kinase-dead BRAF and an oncogenic KRAS gain-of-function mutation in juvenile xanthogranuloma.
Seidel MG; Brcic L; Hoefler G; Hutter C; Minkov M; Steffen LS; Zebisch A; Benesch M
Pediatr Blood Cancer; 2023 Apr; 70(4):e30060. PubMed ID: 36317675
[No Abstract] [Full Text] [Related]
110. Histopathology and levels of proteins in plasma associate with survival after colorectal cancer diagnosis.
Magnusson MI; Agnarsson BA; Jonasson JG; Tryggvason T; Aeffner F; le Roux L; Magnusdottir DN; Gunnarsdottir HS; Alexíusdóttir KK; Gunnarsdottir K; Söebech E; Runarsdottir H; Jonsdottir EM; Kristinsdottir BS; Olafsson S; Knutsdottir H; Thorsteinsdottir U; Ulfarsson MO; Gudbjartsson DF; Saemundsdottir J; Magnusson OT; Norddahl GL; Watson JEV; Rafnar T; Lund SH; Stefansson K
Br J Cancer; 2023 Oct; 129(7):1142-1151. PubMed ID: 37596405
[TBL] [Abstract][Full Text] [Related]
111. Clinical implications of BRAF mutation test in colorectal cancer.
Nazemalhosseini Mojarad E; Farahani RK; Haghighi MM; Aghdaei HA; Kuppen PJ; Zali MR
Gastroenterol Hepatol Bed Bench; 2013; 6(1):6-13. PubMed ID: 24834238
[TBL] [Abstract][Full Text] [Related]
112. Cross-species analysis of genetically engineered mouse models of MAPK-driven colorectal cancer identifies hallmarks of the human disease.
Belmont PJ; Budinska E; Jiang P; Sinnamon MJ; Coffee E; Roper J; Xie T; Rejto PA; Derkits S; Sansom OJ; Delorenzi M; Tejpar S; Hung KE; Martin ES
Dis Model Mech; 2014 Jun; 7(6):613-23. PubMed ID: 24742783
[TBL] [Abstract][Full Text] [Related]
113. High expression of
Tian Y; Liang P; Zhang L; Zhang X; Wang X; Jin Y; Qi X; Liu Y
J Gastrointest Oncol; 2021 Dec; 12(6):2872-2881. PubMed ID: 35070414
[TBL] [Abstract][Full Text] [Related]
114. Don't abandon BRAF-mutated patients with peritoneal metastasis! Re: « Therapeutic implications of B-RAF mutations in colorectal cancer ».
Noiret B; Piessen G; Eveno C
J Visc Surg; 2022 Feb; 159(1):85. PubMed ID: 34802948
[No Abstract] [Full Text] [Related]
115. [Ⅱ.BRAF-Mutated Colorectal Cancer-Up-to-Date Evidence and Clinical Practice].
Okura M; Mitani S
Gan To Kagaku Ryoho; 2022 Nov; 49(11):1216-1220. PubMed ID: 36412023
[No Abstract] [Full Text] [Related]
116. Resistin-like beta reduction is associated to low survival rate and is downregulated by adjuvant therapy in colorectal cancer patients.
Di Rosa M; Di Cataldo A; Broggi G; Caltabiano R; Tibullo D; Castrogiovanni P; Imbesi R; Lanteri R; Salomone F; Raciti G; Li Volti G
Sci Rep; 2023 Jan; 13(1):1490. PubMed ID: 36707698
[TBL] [Abstract][Full Text] [Related]
117. Chitinase domain containing 1 increase is associated with low survival rate and M0 macrophages infiltrates in colorectal cancer patients.
Castrogiovanni P; Barbagallo I; Imbesi R; Musumeci G; Sanfilippo C; Broggi G; Caltabiano R; Tibullo D; Giallongo C; Forte S; Li Volti G; Di Rosa M
Pathol Res Pract; 2022 Sep; 237():154038. PubMed ID: 35932496
[TBL] [Abstract][Full Text] [Related]
118. The Clinicopathological Characteristics of POLE-mutated Colorectal Cancer and the Prognostic Value of POLE Status.
Wu Q; Luo Y; Zhang S; Xie X
Clin Oncol (R Coll Radiol); 2023 Sep; 35(9):e563-e565. PubMed ID: 37286436
[No Abstract] [Full Text] [Related]
119. Antitumor Efficacy of Dual Blockade with Encorafenib + Cetuximab in Combination with Chemotherapy in Human BRAFV600E-Mutant Colorectal Cancer.
Napolitano S; Woods M; Lee HM; De Falco V; Martini G; Della Corte CM; Martinelli E; Famiglietti V; Ciardiello D; Anderson A; Fowlkes NW; Villareal OE; Sorokin A; Kanikarla P; Coker O; Morris V; Altucci L; Tabernero J; Troiani T; Ciardiello F; Kopetz S
Clin Cancer Res; 2023 Jun; 29(12):2299-2309. PubMed ID: 37040395
[TBL] [Abstract][Full Text] [Related]
120. The Spectrum, Tendency and Predictive Value of
Fu X; Lin H; Fan X; Zhu Y; Wang C; Chen Z; Tan X; Huang J; Cai Y; Huang Y
Front Oncol; 2021; 11():595675. PubMed ID: 33842311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
